We firstly found that Sam68 expression levels in sunitinib sensitive RCC tumor tissues were higher than in sunitinib resistant ones, and the Sam68 expression level was correlated with sunitinib sensitivity in ccRCC patients. The gene discussed is KHDRBS1; the disease is renal cell carcinoma.